Qing Yi, MD, PhD

Projects

Projects per year 2016 2019 2023 2024 2029

• 2 Not started
• 6 Finished
• 10 Active

Projects per year

Search results

• Active

  Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib

  Pingali, S. R., Ganguly, S., Mathur, S., Shah, S. & Yi, Q.

  7/29/24 → …

  Project: Clinical Trial

• Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy

  Yi, Q.

  6/1/24 → 5/31/29

  Project: Federal Funding Agencies

• Validating Novel Biologic Mediators and Therapeutic Targets in t(4;14) Myeloma

  Yi, Q.

  4/1/24 → 4/1/27

  Project: Non Profit

• Combination Therapy Using ATRA and Carfilzomib to Treat Proteasome Inhibitor Refractory Multiple Myeloma

  Yi, Q.

  3/1/24 → 2/28/28

  Project: State

• Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors

  Yi, Q.

  1/1/24 → 12/31/28

  Project: Federal Funding Agencies

• Role of lipid metabolism in CD8+ T cell ferroptosis

  Yi, Q.

  9/19/23 → 8/31/28

  Project: Federal Funding Agencies

• Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells

  Yi, Q.

  8/1/23 → 7/31/28

  Project: Federal Funding Agencies

• DEVELOPING NOVEL CAR-T CELL THERAPY FOR HEMATOLOGIC MALIGNANCIES

  Yi, Q.

  7/1/23 → 6/30/26

  Project: Non Profit

• Targeting DKK1 with a DNA vaccine to prevent development of multiple myeloma

  Yi, Q.

  6/26/23 → 12/25/25

  Project: Federal Funding Agencies

• Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion

  Yi, Q.

  8/1/19 → 7/31/25

  Project: Federal Funding Agencies